Lindbrook Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $19.2K | Buy |
478
+194
| +68% | +$7.8K | ﹤0.01% | 1370 |
|
|
2024
Q4 | $13.4K | Sell |
284
-178
| -39% | -$8.37K | ﹤0.01% | 1496 |
|
|
2024
Q3 | $24.4K | Buy |
462
+135
| +41% | +$7.13K | ﹤0.01% | 1188 |
|
|
2024
Q2 | $17.7K | Buy |
327
+129
| +65% | +$6.99K | ﹤0.01% | 1314 |
|
|
2024
Q1 | $13.9K | Buy |
198
+8
| +4% | +$561 | ﹤0.01% | 1390 |
|
|
2023
Q4 | $15.9K | Sell |
190
-107
| -36% | -$8.93K | ﹤0.01% | 1310 |
|
|
2023
Q3 | $8.75K | Sell |
297
-11
| -4% | -$324 | ﹤0.01% | 1482 |
|
|
2023
Q2 | $10K | Buy |
308
+50
| +19% | +$1.63K | ﹤0.01% | 1465 |
|
|
2023
Q1 | $9.08K | Sell |
258
-173
| -40% | -$6.09K | ﹤0.01% | 1507 |
|
|
2022
Q4 | $19.7K | Sell |
431
-167
| -28% | -$7.65K | ﹤0.01% | 1069 |
|
|
2022
Q3 | $29K | Buy |
598
+110
| +23% | +$5.33K | ﹤0.01% | 825 |
|
|
2022
Q2 | $19K | Buy |
488
+56
| +13% | +$2.18K | ﹤0.01% | 983 |
|
|
2022
Q1 | $16K | Buy |
432
+282
| +188% | +$10.4K | ﹤0.01% | 1093 |
|
|
2021
Q4 | $7K | Buy |
150
+100
| +200% | +$4.67K | ﹤0.01% | 1394 |
|
|
2021
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 1520 |
|